| Bioactivity | BPC 157 is a stable gastric pentadecapeptide and a partial sequence of the human gastric juice protein BPC. BPC 157 is an anti-ulcer peptidergic agent with no reported toxicity. BPC 157 links inflammatory bowel disease and multiple sclerosis[1][2]. | ||||||
| Name | BPC 157 | ||||||
| CAS | 137525-51-0 | ||||||
| Formula | C62H98N16O22 | ||||||
| Molar Mass | 1419.54 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
BPC 157
CAS: 137525-51-0 F: C62H98N16O22 W: 1419.54
BPC 157 is a stable gastric pentadecapeptide and a partial sequence of the human gastric juice protein BPC. BPC 157 is a
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.